Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01355562
What this trial is testing

Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer

Who this might be right for
MelanomaMetastatic Kidney Cancer
Loma Linda University
Testing effectiveness (Phase 2)Ended earlyNCT02495103
What this trial is testing

Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaHereditary LeiomyomatosisRenal Cell Cancer
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT00001383
What this trial is testing

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerCancerCarcinoma, Renal Cell+2 more
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Looking for participantsNCT06005818
What this trial is testing

Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
University of Alabama at Birmingham 100
Testing effectiveness (Phase 2)Study completedNCT01053013
What this trial is testing

Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectablePancreatic Adenocarcinoma MetastaticColorectal Cancer Metastatic
The Rogosin Institute 58
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)Looking for participantsNCT07748988
What this trial is testing

Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Refractory Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma
Vanderbilt-Ingram Cancer Center 12
Not applicableStudy completedNCT00900042
What this trial is testing

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 34
Large-scale testing (Phase 3)Active Not RecruitingNCT05678673
What this trial is testing

Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
Exelixis 317
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT01571401
What this trial is testing

Trying Activity in Kidney Cancer Survivors (TRACKS) Trial

Who this might be right for
Supervised Physical Activity Plus Exercise CounselingSupervised Physical Activity Plus Behavioural Counseling
University of Alberta 32
Not applicableStudy completedNCT01908166
What this trial is testing

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

Who this might be right for
Adult Primary Liver CancerKidney Tumor
Stanford University 61
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Not applicableUnknownNCT02208128
What this trial is testing

Molecular Determinants for Therapy Response on Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Heidelberg University 4
Not applicableLooking for participantsNCT06908902
What this trial is testing

Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal Tumors

Who this might be right for
RCC, Renal Cell CancerPartial Nephrectomy
The First Affiliated Hospital with Nanjing Medical University 60
Not applicableStudy completedNCT01002937
What this trial is testing

Novel Prognostic Markers in Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Royal Marsden NHS Foundation Trust 182
Testing effectiveness (Phase 2)Study completedNCT00005045
What this trial is testing

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Not applicableUnknownNCT04424472
What this trial is testing

Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas Medical Center 50
Not applicableWithdrawnNCT01642095
What this trial is testing

Studying Biomarkers in Samples From Younger Patients With Kidney Cancer

Who this might be right for
Childhood Kidney NeoplasmClear Cell Renal Cell CarcinomaCongenital Mesoblastic Nephroma+1 more
Children's Oncology Group
Large-scale testing (Phase 3)Not Yet RecruitingNCT07338981
What this trial is testing

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

Who this might be right for
Advanced Kidney Cancer
Guliz Ozgun 142
Next Page